Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Committee for medicinal products for human use (CHMP) – Minutes for the meeting on 24-26 April 2023
EU-minutes-chmp-meeting-24-26-april-2023_Published-on-07July2023-1Download
Ryan McArthur 13 July 2023 All news
  • ← Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 – 6 July 2023
  • Notice to sponsors of clinical trials on medicinal products including advanced therapy medicinal products – Volume II Clinical trial vigilance →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • The ANSM publishes its haemovigilance report for 2023
  • User’s booklet – ANSM
  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2024
Copyright © 2018 - Pharmya - Legal terms - Quality Policy